3-(methylnitrosamino)propionitrile: formed from the alkaloid of betel quid [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 62163 |
| CHEBI ID | 82359 |
| SCHEMBL ID | 3823907 |
| MeSH ID | M0124656 |
| Synonym |
|---|
| propanenitrile, 3-(methylnitrosoamino)- |
| propionitrile, 3-(methylnitrosamino)- |
| mnpn |
| 3-methylnitrosaminopropionitrile |
| 3-(n-nitrosomethylamino)propionitrile |
| 3-(methylnitrosoamino)propanenitrile |
| brn 2348789 |
| propanenitrile, 3-(methylnitrosoamino)-, (4alpha)- |
| ccris 398 |
| 3-(methylnitrosamino)propionitrile |
| n-(2-cyanoethyl)-n-methylnitrous amide |
| AKOS006278449 |
| 60153-49-3 |
| C19280 |
| kh5h2t1w5k , |
| unii-kh5h2t1w5k |
| FT-0672055 |
| CHEBI:82359 |
| SCHEMBL3823907 |
| 3-(n-nitrosomethylamino)propio-nitrile |
| Q27155898 |
| Z1198157818 |
| 3-(n-nitrosomethylamino)propionitrile [iarc] |
| nitrosomethylamino)propionitrile, 3-(n- |
| 3-[methyl(nitroso)amino]propanenitrile |
| DTXSID70975579 |
| propionitrile, 3-(methylnitrosamino). |
| EN300-7475111 |
| STARBLD0029752 |
| Class | Description |
|---|---|
| nitroso compound | Compounds having the nitroso group, -NO, attached to carbon, or to another element, most commonly nitrogen or oxygen. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.01) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||